Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
LY3209590 for Type 2 Diabetes in Children
Recruiting1 awardPhase 1
Los Angeles, California
This trial aims to see how a drug called LY3209590 is absorbed and removed from the body in children with Type 2 Diabetes. The study will take around 100 days to complete.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service